Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 916 of 1,261

  1. US 8217172

    Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  2. US 8217176

    Fused heterocyclic derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  3. US 8217048

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  4. DE 102010064358

    Transdermales Applikationssystem mit überstehender Backingfolie

    ACINO AG [DE] · Granted Jul 5, 2012 · Expires Jun 30, 2032

    granted

  5. US 8211941

    Antagonists of the transient receptor potential vanilloid 1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  6. US 8212029

    Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6H-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  7. US 8211428

    Protease screening methods and proteases identified thereby

    Catalyst Biosciences, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  8. US 8211445

    PSM peptides as vaccine targets against methicillin-resistant Staphylococcus

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  9. US 8212007

    Expression and purification of HIP/PAP and uses therefor

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  10. US 8211422

    Chimeric receptor genes and cells transformed therewith

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  11. US 8212010

    Sphingosine 1-phosphate antagonism

    Expression Drug Designs, LLC · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  12. US 8211884

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  13. US 8211464

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  14. US 8211664

    Methods and materials for making simvastatin and related compounds

    The Regents of the University of California · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  15. US 8211857

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  16. US 8211468

    Endosomolytic polymers

    Arrowhead Madison, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  17. US 8211635

    P53 modulator and cancer target

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  18. US 8211649

    Methods of diagnosing and prognosing hodgkin's lymphoma

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  19. US 8211888

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  20. US 8211889

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  21. US 8211894

    Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  22. US 8211915

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  23. US 8211935

    Heterocyclic derivatives for modulation of calcium channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  24. US 8211934

    Small molecule inhibition of PDZ-domain interaction

    The Regents of the University of California · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.